These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 9482510

  • 1. A placebo-controlled study of the effects of intravenous Buflomedil on foot skin microcirculation in patients with severe intermittent claudication.
    Van den Brande P, Maurel A.
    Angiology; 1998 Feb; 49(2):105-14. PubMed ID: 9482510
    [Abstract] [Full Text] [Related]

  • 2. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
    Trübestein G, Balzer K, Bisler H, Klüken N, Muller-Wiefel H, Unkel B, Mahfoud Y, Ziegler W.
    Angiology; 1984 Aug; 35(8):500-5. PubMed ID: 6383127
    [Abstract] [Full Text] [Related]

  • 3. Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial.
    Arosio E, De Marchi S, Zannoni M, Prior M, Lechi A.
    Mayo Clin Proc; 2002 Aug; 77(8):754-9. PubMed ID: 12173710
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of the effectiveness of intra-arterial and intravenous administration of buflomedil in patients with intermittent claudication].
    Diehm C, Eckstein M, Hübsch-Müller C.
    Vasa; 1989 Aug; 18(1):40-7. PubMed ID: 2648691
    [Abstract] [Full Text] [Related]

  • 5. Buflomedil for intermittent claudication.
    De Backer TL, Vander Stichele RH, Bogaert MG.
    Cochrane Database Syst Rev; 2001 Aug; (1):CD000988. PubMed ID: 11279700
    [Abstract] [Full Text] [Related]

  • 6. [Action of Buflomedil on the cutaneous microcirculation studies by a cold provocation test. Multicenter, double-blind, placebo controlled trial].
    Maurel A, Betrancourt JC, Van Frenkel R, Thuillez C.
    J Mal Vasc; 1995 Aug; 20(2):127-33. PubMed ID: 7650439
    [Abstract] [Full Text] [Related]

  • 7. Improvement of microcirculation abnormalities in sickle cell patients upon buflomedil treatment.
    Bachir D, Maurel A, Beuzard Y, Razavian M, Kraiem A, Portos JL, Galacteros F.
    Microvasc Res; 1993 Nov; 46(3):359-73. PubMed ID: 8121319
    [Abstract] [Full Text] [Related]

  • 8. A review of long-term safety data with buflomedil.
    Bachand RT, Dubourg AY.
    J Int Med Res; 1990 Nov; 18(3):245-52. PubMed ID: 2193838
    [Abstract] [Full Text] [Related]

  • 9. Laser Doppler flux characteristics at the skin of the dorsum of the foot in young and in elderly healthy human subjects.
    Van den Brande P, von Kemp K, De Coninck A, Debing E.
    Microvasc Res; 1997 Mar; 53(2):156-62. PubMed ID: 9143547
    [Abstract] [Full Text] [Related]

  • 10. Comparative evaluation of pentoxifylline, buflomedil, and nifedipine in the treatment of intermittent claudication of the lower limbs.
    Chacón-Quevedo A, Eguaras MG, Calleja F, Garcia MA, Roman M, Casares J, Muñoz I, Concha M.
    Angiology; 1994 Jul; 45(7):647-53. PubMed ID: 8024164
    [Abstract] [Full Text] [Related]

  • 11. Circadian variation of skin perfusion in arterial occlusive disease.
    Caspary L, Nordbruch S, Lange R, Creutzig A.
    Vasa; 1997 Aug; 26(3):194-8. PubMed ID: 9286151
    [Abstract] [Full Text] [Related]

  • 12. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
    Diamantopoulos EJ, Grigoriadou M, Ifanti G, Raptis SA.
    Int Angiol; 2001 Dec; 20(4):337-44. PubMed ID: 11782701
    [Abstract] [Full Text] [Related]

  • 13. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    Limbs International Medicinal Buflomedil (LIMB) Study Group, Leizorovicz A, Becker F.
    Circulation; 2008 Feb 12; 117(6):816-22. PubMed ID: 18212283
    [Abstract] [Full Text] [Related]

  • 14. Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease.
    Edvinsson LI, Edvinsson ML, Angus Deveber G.
    Int Angiol; 2003 Jun 12; 22(2):141-7. PubMed ID: 12865879
    [Abstract] [Full Text] [Related]

  • 15. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
    Joffre F, Meites G, Rousseau H, Staffin C, Allaert FA, Pelat P.
    Ann Radiol (Paris); 1994 Jun 12; 37(3):239-44. PubMed ID: 8092756
    [Abstract] [Full Text] [Related]

  • 16. Short-range intermittent claudication and rest pain: microcirculatory effects of pentoxifylline in a randomized, controlled trial.
    Incandela L, De Sanctis MT, Cesarone MR, Belcaro G, Nicolaides AN, Geroulakos G, Ramaswami G.
    Angiology; 2002 Jun 12; 53 Suppl 1():S27-30. PubMed ID: 11865832
    [Abstract] [Full Text] [Related]

  • 17. Disturbances of cutaneous microcirculatory autoregulation in arterial occlusive disease.
    Van den Brande P.
    Angiology; 1988 Nov 12; 39(11):960-6. PubMed ID: 3052184
    [Abstract] [Full Text] [Related]

  • 18. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation.
    De Sanctis MT, Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, Incandela L, Bucci M, Geroulakos G, Ramaswami G, Vasdekis S, Agus G, Bavera P, Ippolito E.
    Angiology; 2002 Nov 12; 53 Suppl 1():S7-12. PubMed ID: 11865838
    [Abstract] [Full Text] [Related]

  • 19. Laser Doppler flowmetry, transcutaneous oxygen pressure and thermal clearance in patients with vascular intermittent claudication.
    Saumet JL, Fabry R, Girard P, Saumet M, Abraham P, Schaff G.
    Int J Microcirc Clin Exp; 1993 Apr 12; 12(2):173-83. PubMed ID: 8500976
    [Abstract] [Full Text] [Related]

  • 20. Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.
    Thum J, Caspary L, Creutzig A, Alexander K.
    Vasa; 1998 May 12; 27(2):100-5. PubMed ID: 9612114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.